Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neopl... by Halpern, Anna B., Rodríguez-Arbolí, Eduardo P, Othus, Megan, Garcia, Kelsey-Leigh A, Percival, Mary-Elizabeth M., Cassaday, Ryan D., Oehler, Vivian G., Becker, Pamela S., Appelbaum, Jacob S., Abkowitz, Janis L., Orozco, Johnnie J., Keel, Sioban B., Hendrie, Paul C., Scott, Bart L., Ghiuzeli, Cristina, Walter, Roland B., Estey, Elihu H.

Get full text

Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial by Wang, Eunice S, Issa, Ghayas C, Erba, Harry P, Altman, Jessica K, Montesinos, Pau, DeBotton, Stephane, Walter, Roland B, Pettit, Kristen, Savona, Michael R, Shah, Mithun Vinod, Kremyanskaya, Marina, Baer, Maria R, Foran, James M, Schiller, Gary, Adès, Lionel, Heiblig, Mael, Berthon, Celine, Peterlin, Pierre, Rodríguez-Arbolí, Eduardo, Salamero, Olga, Patnaik, Mrinal M, Papayannidis, Cristina, Grembecka, Jolanta, Cierpicki, Tomasz, Clegg, Bradley, Ray, Joshua, Linhares, Brian M, Nie, Kun, Mitra, Amitava, Ahsan, Julie Mackey, Tabachri, Marilyn, Soifer, Harris S, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Fathi, Amir T

Get full text

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16/NKG2D Immune Modulating TriNKET ® BMS-986357 (CC-96191) by Lunn, Margaret C., Laszlo, George S., Eraiss, Sarah, Orr, Mark T., Jessup, Heidi K., Chan, Henry, Thomas, Heather J., Cheung, Ann F., Chang, Gregory P., Grinberg, Asya, Rodríguez-Arbolí, Eduardo, Lim, Sheryl Y. T., Kehret, Allie R., Huo, Jenny, Cole, Frances M., Scharffenberger, Samuel C., Walter, Roland B.

Get full text

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ® CC-96191 by Lunn-Halbert, Margaret C, Laszlo, George S, Erraiss, Sarah, Orr, Mark T, Jessup, Heidi K, Thomas, Heather J, Chan, Henry, Jahromi, Mahan A, Lloyd, Jonathan, Cheung, Ann F, Chang, Gregory P, Dichwalkar, Tanmay, Fallon, Daniel, Grinberg, Asya, Rodríguez-Arbolí, Eduardo, Lim, Sheryl Y T, Kehret, Allie R, Huo, Jenny, Cole, Frances M, Scharffenberger, Samuel C, Walter, Roland B

Get full text

Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Gra... by Godwin, Colin, Rodríguez-Arbolí, Eduardo, Othus, Megan, Halpern, Anna, Appelbaum, Jacob, Percival, Mary-Elizabeth, Hendrie, Paul, Oehler, Vivian, Keel, Siobán, Abkowitz, Janis, Cooper, Jason, Cassaday, Ryan, Estey, Elihu, Walter, Roland

Get full text

Preliminary Safety, Efficacy, and Molecular Characterization of Emavusertib (CA-4948) in Relapsed/Refractory Acute Myeloid Leukemia Patients by Winer, Eric S., Sallman, David, De la Fuente Burguera, Adolfo, Verma, Amit, Goetze, Katharina, Abaza, Yasmin, Dugan, James P., Cluzeau, Thomas, Rodriguez Arboli, Eduardo, Mims, Alice, Groepper, Stefanie, Zilbershatz, Itay, Liesveld, Jane L., Fiedler, Walter, Tarantolo, Stefano R, Ades, Lionel, Papadantonakis, Nikolaos, Schliemann, Christoph, Choudhary, Gaurav S, Lane, Maureen, Zhao, Wanying, Jain, Ashish, Gallagher, Cole, Garcia-Manero, Guillermo

Get full text